The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...

Both semaglutide and tirzepatide were shown to “significantly reduce” the risk of hospitalization and all-cause mortality for heart failure patients, according to a study published Aug. 31 in JAMA.

Heart disease medication plays a critical role in managing and preventing cardiovascular conditions. Understanding the various types, their mechanisms, and how they work can help people make informed ...

Heart failure experts are warning that despite seeing some of cardiology’s most exciting therapeutic advances over the last decade, their field has a serious pipeline problem. Unless steps are taken ...

In June of 2022, a report from the American Diabetes Association highlighted heart failure as “an underappreciated complication of diabetes.” According to that report, up to 22% of people with ...